Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 8/20 | 0.66 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.66 |
| ▸ | OPRK1 | P41145 | 5/20 | 0.66 |
| ▸ | MRGPRX2 | Q96LB1 | 4/20 | 0.66 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.66 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.66 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.66 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.59 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.59 |
| ▸ | ARRB1 | P49407 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16570950 | 1.00 | OPRD1 (0.66) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| SCHEMBL30620560 | 1.00 | OPRD1 (0.66) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| SCHEMBL28468334 | 0.89 | OPRM1 (0.62) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| SCHEMBL29416620 | 0.85 | OPRD1 (0.78) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| SCHEMBL547917 | 0.85 | OPRD1 (0.78) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| SCHEMBL28470432 | 0.84 | OPRD1 (0.63) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| SCHEMBL10243104 | 0.84 | OPRM1 (0.65) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| Codeine SCHEMBL3475523 | 0.83 | OPRD1 (0.88) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 | |
| Morphine SCHEMBL28712434 | 0.83 | OPRD1 (0.78) | OPRD1OPRM1OPRK1MRGPRX2SLC22A1 | |
| Codeine SCHEMBL4730550 | 0.82 | OPRD1 (0.72) | OPRD1OPRM1OPRK1MRGPRX2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120726569-B | Distribution network telegraph pole inclination detection method, system, equipment and medium | 广东电网有限责任公司中山供电局 | 2026-05-15 | — | — | CN | disclosed |
| US-20250268090-A1 | Display Device, Display Module, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2025-08-21 | — | — | US | disclosed |
| US-12263200-B2 | Specific nutritional or therapeutic agent including a mixture of grape and blueberry | ACTIV'INSIDE | 2025-04-01 | — | — | US | disclosed |
| CN-117024395-B | Be used for detecting H2S flavonol derivative fluorescent probe and preparation method and application thereof | 西北大学 | 2025-02-28 | — | — | CN | disclosed |
| WO-2025021702-A1 | CAS9 ORTHOLOGUE NUCLEASE AND USES THEREOF | ALIA THERAPEUTICS S.R.L. (IT) | 2025-01-30 | — | — | WO | disclosed |
| CN-119256084-A | Treatment of hematological malignancies | 莱顿大学医学中心附属莱顿教学医院 | 2025-01-03 | — | — | CN | disclosed |
| CN-115131783-B | Autonomous sensing method of user diet nutrition ingredient information based on machine vision | 贵州大学 | 2024-02-20 | — | — | CN | disclosed |
| CN-117024395-A | Be used for detecting H 2 S flavonol derivative fluorescent probe and preparation method and application thereof | 西北大学 | 2023-11-10 | — | — | CN | disclosed |
| US-20230024908-A1 | SPECIFIC NUTRITIONAL OR THERAPEUTIC AGENT INCLUDING A MIXTURE OF GRAPE AND BLUEBERRY | ACTIV'INSIDE (FR) | 2023-01-26 | — | — | US | disclosed |
| EP-3681859-B1 | GENE CLUSTER FOR THE BIOSYNTHETIC PRODUCTION OF TETRACYCLINE COMPOUNDS IN A HETEROLOGOUS HOST | HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) | 2022-10-26 | — | — | EP | disclosed |
| US-11469380-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2022-10-11 | — | — | US | disclosed |
| EP-4003710-A1 | A PROCESS AND A DEVICE ASSEMBLY USEFUL FOR PRODUCING A MOLDED SILICONE RUBBER PRODUCT FROM LIQUID SILICONE RUBBER COMPOSITION VIA INJECTION MOLDING | Elkem Silicones USA Corp. (US) | 2022-06-01 | — | — | EP | disclosed |
| US-11266705-B2 | Specific nutritional or therapeutic agent including a mixture of grape and blueberry | SPECIALITES PET FOOD (FR) | 2022-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11469380-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device | CCNE2, CCND2, CCND1 | OPRD1 215/4885OPRM1 613/4885OPRK1 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.